Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00425568 · ClinicalTrials.gov registry record
Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR
A clinical trial of Hypogonadism, sponsored by Lamm, Steven, M.D..
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT00425568: Completed study of Hypogonadism, sponsored by Lamm, Steven, M.D..
NCT00425568 is a study of Hypogonadism that has completed, run by Lamm, Steven, M.D.. The registered enrollment target is 30 participants, below the 119-participant average among 21 other Hypogonadism trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00425568, a study of Hypogonadism, has completed, sponsored by Lamm, Steven, M.D..
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Low testosterone may be responsible for "soft" erections in men. The purpose of our study is to see whether the daily application of a testosterone gel to raise testosterone levels will also increase the "hardness" of a man's erection.
Conditions Studied
Interventions
- DRUG AndroGel (Transdermal Testosterone Gel)
Study Locations (1)
New York
- Steven Lamm, M.D. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-12 |
What the finished NCT00425568 record still lists
NCT00425568 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 119-participant average among 21 other Hypogonadism trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Hypogonadism appearing as the primary indexed condition, and to 1 intervention - of which AndroGel (Transdermal Testosterone Gel) is the first listed.
NCT00425568 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00425568 about?
NCT00425568 is a clinical study titled "Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR". Low testosterone may be responsible for "soft" erections in men. The purpose of our study is to see whether the daily application of a testosterone gel to raise testosterone levels will also increase the "hardness" of a man's erection.
What is the current status of trial NCT00425568?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2005-12.
What conditions does trial NCT00425568 study?
This clinical trial studies the following conditions: Hypogonadism.
What interventions are being tested in trial NCT00425568?
The interventions under investigation include: AndroGel (Transdermal Testosterone Gel) (DRUG).
Who is sponsoring clinical trial NCT00425568?
This trial is sponsored by Lamm, Steven, M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00425568 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypogonadism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00425568's enrollment target sits among peer trials
30 17th of 21 higher than 5 of 21 other Hypogonadism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypogonadism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Observation of Environment and Reproductive-Endocrine Effects
RECRUITING
-
Adaptions and Resiliency to Multi-Stressor OpeRations
RECRUITING · Phase 4
-
Inherited Reproductive Disorders
RECRUITING
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
RECRUITING
-
A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia